Peptide Stock Finder
Growth hormone · Human trials

Tesamorelin

Also known as Egrifta, TH9507

Tesamorelin is a stabilised analogue of growth hormone releasing hormone. Unlike most compounds in this reference it has been approved by the FDA, for a narrow indication: reduction of excess abdominal fat in people with HIV-associated lipodystrophy. It has therefore been through full clinical trials for that use.

Who has Tesamorelin in stock

SupplierListingPricePer mg
Peptides UKBest valueUKTesamorelin 2mg£24.95£12.48In stock, go
HiPeptidesUKTesamorelin£39.99–In stock, go
PEAK_PEPTIDEInternationalTesamorelin€54.90–In stock, go
AminoPeptidesUKTesamorelin 10mg + Ipamorelin 2mg Peptide Bundle£65.00–In stock, go

Live stock is checked hourly at 10 suppliers. A further 7 vetted suppliers have no live feed yet, so we never show them as in stock. We earn a commission from some supplier links when you buy. It costs you nothing extra and never changes the order, which is by price per mg.

What it has been studied for

  • Phase 3 trials in HIV-associated lipodystrophy
  • Visceral adipose tissue measured by CT in those trials
  • IGF-1 response and growth hormone axis effects
  • Cognitive endpoints in small exploratory studies

Evidence level: Human trials. Human data exists, but read the details above before assuming it applies to you.

What happened in human trials

Licensed in the US for HIV-related belly fat. In its trials, 13% had joint pain, 9% injection site redness and 6% swelling in the legs or hands. It raised blood sugar in some people, and many developed antibodies to it.

Prohibited in drug-tested sport under the World Anti-Doping Code.

UK legal status

Not licensed as a medicine in the UK. Approved in the United States for a specific indication only. Prohibited in sport under WADA class S2.

Handling

The licensed product is supplied as a lyophilised powder for reconstitution, with manufacturer instructions that take precedence over anything general. Commonly 1mg or 2mg per vial.

Questions

Is tesamorelin approved in the UK?

No. It holds FDA approval in the United States for HIV-associated lipodystrophy. It does not hold a UK marketing authorisation.

Before you buy anything, run the four-question check for red flags that apply to you.